Effectiveness of neoadjuvant chemotherapy with a docetaxel, cisplatin, and S-1 (DCS) regimen for T4b gastric cancer
Neoadjuvant chemotherapy with DCS regimen demonstrated a high tolerance, high tumor response rate, high complete adjuvant chemotherapy rate and satisfactory 3-year survival outcomes. Three- or four-course of preoperative DCS regimen is a promising approach for GC with T4b stage.
Authors
- Vo Duy Long (ORCID: https://orcid.org/0000-0002-7088-5532)
- Tran Quang Dat
- Doan Thuy Nguyen (ORCID: https://orcid.org/0009-0005-3058-3416)
- Dang Quang Thong (ORCID: https://orcid.org/0000-0003-1206-8881)
- Nguyen Lam Vuong (ORCID: https://orcid.org/0000-0003-2684-3041)
- Nguyễn Hoàng Bắc (ORCID: https://orcid.org/0000-0002-2973-7909)
- Lam Quoc Trung
- Nguyen Viet Haı
- Tran Duy Phuoc
Institutions
- Ho Chi Minh City University of Science (VN)
- University of Medicine and Pharmacy at Ho Chi Minh City (VN)
- University Medical Center HCMC (VN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1186/s12957-024-03620-1
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.42